evidence table
Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial Evidence Table
Structured evidence table for Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Blood glucose level, glycated hemoglobin level, body weight, and fat mass decreased with green tea intervention, while muscle mass increased across all groups (all p Trial Registration: University Hospital Medical Information Network (UMIN): UMIN000058708. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Catechins in green tea have been reported to enhance glucose tolerance and lipid metabolism. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | However, the influence of chronic intake timing on these outcomes in older adults has not been fully elucidated. | 2 | Fuke S (2026) | Effects of Green Tea-Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8-Week Randomized Controlled Trial. |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Beyond sharing common risk factors with metabolic disorders including diabetes, obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular (CV) diseases, CKD is characterized by chronic and prolonged exposure to bioactive metabolites known as uremic toxins (UTs), which exert many deleterious systemic effects. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Recent experimental and clinical data have nevertheless improved the classification of UTs according to their origin and biological activity, allowing for better identification of actionable sources. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Therefore, the accumulation and high concentrations of UTs in the bloodstream of CKD patients result from a combination of impaired kidney function leading to reduced clearance, increased de novo production driven by CKD-associated dysbiosis, and enhanced gut permeability (often referred to as “leaky gut”) []. | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
| Green Tea Intake Timing Glucose Lipid Metabolism Randomized Trial | Nutrition remains a cornerstone in the management of chronic kidney disease (CKD), acting in synergy with recent pharmacological advances such as sodium–glucose cotransporter 2 inhibitors (SGLT2is), renin–angiotensin–aldosterone system inhibitors (RAASis), and glucagon-like peptide-1 receptor agonists (GLP-1RAs). | 3 | Jouve Fanny (2026) | Nutritional Factors Affecting Uremic Toxin Production |
Source documents